Treatment of mesenchymal stem cells with a glucocorticoid together with an agent that increases intracellular cAMP is disclosed as one of several methods for inducing the differentiation of mesenchymal stem cells into adipocytes.
View this patent on the USPTO website.
 
  
  
  
  
  
  
  
  
  
  
       
    Add Comment
 Add CommentYou must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.